Use of a biochip assaying 28 mutations in the KRAS, BRAF, TP53, and APC genes for detection of colorectal neoplasia

被引：1

作者：

Hughes, D. ^{[1
]}

O'Morain, C. ^{[1
]}

Lee, N. ^{[1
]}

Kelley, L. ^{[1
]}

McMurray, H. ^{[2
]}

Latten, M. ^{[2
]}

Ebert, M. ^{[3
]}

机构：

[1] AMNCH Hosp, Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland

[2] Randox Labs, DNA Diagnost, Crumlin, Ireland

[3] Tech Univ Munich, Munich, Germany

来源：

EJC SUPPLEMENTS | 2010年 / 8卷 / 05期

关键词：

D O I：

10.1016/S1359-6349(10)70936-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

128

引用

页码：33 / 34

页数：3

共 50 条

[31] Detection of TP53 Mutations in the Peritoneal Washings of Women with Germline Mutations in Ovarian Cancer Susceptibility Genes
Goebel, Emily
Qian, Xiaohua
Xie, Jingzhong
Chapel, David
Hill, Sarah
Garber, Judy
Xian, Wa
Crum, Christopher
MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1063 - 1064
[32] Comparing ion torrent with pyrosequencing and Sanger sequencing for the detection of TP53 mutations in colorectal cancer
Brendan Doyle
Clarence C Lee
Timothy T Harkins
Rosella Petraroli
Paul Smyth
Kieran Sheahan
John J O’Leary
Orla Sheils
EPMA Journal, 2014, 5 (Suppl 1):
[33] Clinical, Pathological and Molecular Insights on KRAS, NRAS, BRAF, PIK3CA and TP53 Mutations in Metastatic Colorectal Cancer Patients from Northeastern Romania
Afrasanie, Vlad-Adrian
Marinca, Mihai-Vasile
Gafton, Bogdan
Alexa-Stratulat, Teodora
Rusu, Alexandra
Froicu, Eliza-Maria
Sur, Daniel
Lungulescu, Cristian Virgil
Popovici, Larisa
Lefter, Andrei-Vlad
Afrasanie, Irina
Ivanov, Anca-Viorica
Miron, Lucian
Rusu, Cristina
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
[34] TP53 mutations in irinotecan-refractory KRAS wt-BRAF wt metastatic colorectal cancer patients treated with cetuximab-based chemotherapy.
Di Fiore, F.
Lamy, A.
Blanchard, F.
Oden-Gangloff, A.
Sesbouee, R.
Sabourin, J.
Frebourg, T.
Michel, P.
Laurent-Puig, P.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
[35] Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer
Samowitz, WS
Wolff, RK
Ma, KN
Andersen, K
Caan, B
Slattery, ML
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 595 (1-2) : 117 - 124
[36] Expression of PD-L1 in colorectal cancer that lack mutations in RAS or TP53 genes.
Albitar, Maher
Sudarsanam, Sucha
Ma, Wanlong
Jiang, Shiping
Chen, Wayne
Funari, Vincent Anthony
Agersborg, Sally
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[37] Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer
Marbun, Vania Myralda Giamour
Erlina, Linda
Lalisang, Toar Jean Maurice
PLOS ONE, 2022, 17 (06):
[38] Co-mutations of KRAS/BRAF and TP53 or the high tumor mutation burden to predict survival in patients with biliary tract carcinoma.
Guo, Lingling
Kou, Xiaoxia
Song, Panpan
Zhang, Xiaoyu
Zhang, Hongjuan
Qiu, Jinrong
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[39] Frequent Mutations in EGFR, KRAS and TP53 Genes in Human Lung Cancer Tumors Detected by Ion Torrent DNA Sequencing
Cai, Xin
Sheng, Jianhui
Tang, Chuanning
Nandakumar, Vijayalakshmi
Ye, Hua
Ji, Hong
Tang, Haiying
Qin, Yu
Guan, Hongwei
Lou, Feng
Zhang, Dandan
Sun, Hong
Dong, Haichao
Zhang, Guangchun
Liu, Zhiyuan
Dong, Zhishou
Guo, Baishuai
Yan, He
Yan, Chaowei
Wang, Lu
Su, Ziyi
Li, Yangyang
Jones, Lindsey
Huang, Xue F.
Chen, Si-Yi
Wu, Taihua
Lin, Hongli
PLOS ONE, 2014, 9 (04):
[40] Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer
Kleist, Britta
Kempa, Marcel
Novy, Michael
Oberkanins, Christian
Xu, Li
Li, Guojun
Loland, Christiane
Poetsch, Micaela
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 5927 - U1969

← 1 2 3 4 5 →